| 000 | 01155 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514061810.0 | ||
| 264 | 0 | _c20030520 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0953-8194 | ||
| 024 | 7 |
_a10.1046/j.1365-2826.2003.01006.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkene, D J | |
| 245 | 0 | 0 |
_aOptimization of light and melatonin to phase-shift human circadian rhythms. _h[electronic resource] |
| 260 |
_bJournal of neuroendocrinology _cApr 2003 |
||
| 300 |
_a438-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBlindness _xphysiopathology |
| 650 | 0 | 4 |
_aChronobiology Disorders _xradiotherapy |
| 650 | 0 | 4 |
_aCircadian Rhythm _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLight |
| 650 | 0 | 4 |
_aMelatonin _xadministration & dosage |
| 650 | 0 | 4 | _aPhototherapy |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xradiotherapy |
| 650 | 0 | 4 | _aUltraviolet Therapy |
| 773 | 0 |
_tJournal of neuroendocrinology _gvol. 15 _gno. 4 _gp. 438-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2826.2003.01006.x _zAvailable from publisher's website |
| 999 |
_c12418362 _d12418362 |
||